2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one Sporanox (TN) Itrizole (TN) Oriconazole BDBM50127138 ITRACONAZOLE CHEMBL22587
- Pace, JR; DeBerardinis, AM; Sail, V; Tacheva-Grigorova, SK; Chan, KA; Tran, R; Raccuia, DS; Wechsler-Reya, RJ; Hadden, MK Repurposing the Clinically Efficacious Antifungal Agent Itraconazole as an Anticancer Chemotherapeutic. J Med Chem 59: 3635-49 (2016)
- Peng, CC; Shi, W; Lutz, JD; Kunze, KL; Liu, JO; Nelson, WL; Isoherranen, N Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals. Drug Metab Dispos 40: 426-35 (2012)
- Li, Y; Pasunooti, KK; Peng, H; Li, RJ; Shi, WQ; Liu, W; Cheng, Z; Head, SA; Liu, JO Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors. ACS Med Chem Lett 11: 1111-1117 (2020)
- Pace, JR; Teske, KA; Chau, LQ; Dash, RC; Zaino, AM; Wechsler-Reya, RJ; Hadden, MK Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors. J Med Chem 62: 3873-3885 (2019)
- Li, Y; Pasunooti, KK; Li, RJ; Liu, W; Head, SA; Shi, WQ; Liu, JO Novel Tetrazole-Containing Analogues of Itraconazole as Potent Antiangiogenic Agents with Reduced Cytochrome P450 3A4 Inhibition. J Med Chem 61: 11158-11168 (2018)